Home / Healthcare / Pharmaceutical / U.S. Contraceptive Drugs Market
U.S. Contraceptive Drugs Market Size, Share & COVID-19 Impact Analysis, Product (Oral {Combined Contraceptives and Progestin-only Pills}, Injectable, and Patches), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs, and Others), and Country Forecast, 2023-2030
Report Format: PDF | Published Date: Dec, 2023 | Report ID: FBI108733 | Status : Published- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions & Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Total Fertility Rate, U.S., 2022
- Pipeline Analysis, Key Players
- New Product Launches, Key Players
- Regulatory Scenario – U.S.
- Key Industry Developments- Mergers, Partnerships & Acquisitions
- Impact of COVID-19 on the Market
- U.S. Contraceptive Drugs Market Analysis, Insights and Forecast, 2019-2030
- Market Analysis, Insights and Forecast – By Product
- Oral
- Combined Contraceptives
- Progestin-only Pills
- Injectable
- Patches
- Oral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Clinics
- Online Channel
- Public Channel & NGOs
- Others
- Market Analysis, Insights and Forecast – By Product
- Competitive Analysis
- U.S. Market Share Analysis (2022)
- Company Profiles
- Agile Therapeutics
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Johnson & Johnson Services, Inc.
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Abbvie Inc.
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Pfizer Inc.
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Teva Pharmaceutical Industries Ltd.
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Viatris Inc.
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Amneal Pharmaceuticals, Inc.
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Bayer AG
- Overview
- Products
- SWOT Analysis
- Recent Developments
- Strategies
- financials (Based on Availability)
- Agile Therapeutics
List of Figures:
Figure 1: U.S. Contraceptive Drugs Market Revenue Breakdown (USD Billion, %), By Product, 2022 & 2030
Figure 2: U.S. Contraceptive Drugs Market Value Share (%), by Product, 2022 & 2030
Figure 3: U.S. Contraceptive Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030
Figure 4: U.S. Contraceptive Drugs Market Share (%), By Company, 2022
List of Tables:
Table 1: U.S. Contraceptive Drugs Market Revenue (USD Billion) Forecast, by Product, 2019–2030
Table 2: U.S. Contraceptive Drugs Market Revenue (USD Billion) Forecast, by Oral Contraceptives, 2019–2030
Table 3: U.S. Contraceptive Drugs Market Revenue (USD Billion) Forecast, by Distribution Channel, 2019–2030
- 2022
- 2019-2021
- 58